Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway
Conclusion:
GLP-1RA exenatide can inhibit human VSMCs calcification through NF-κB/RANKL signaling.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Jun-Kun ZhanPan TanYan-Jiao WangYi WangJie-Yu HeZhi-Yong TangWu HuangYou-Shuo Liu Source Type: research